255 related articles for article (PubMed ID: 16449117)
1. Single-dose fluconazole for vulvovaginal candidiasis: impact on prothrombin time in women taking warfarin.
Turrentine MA
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):310-3. PubMed ID: 16449117
[TBL] [Abstract][Full Text] [Related]
2. Low-dose fluconazole therapy potentiates the hypoprothrombinemic response of warfarin sodium.
Crussell-Porter LL; Rindone JP; Ford MA; Jaskar DW
Arch Intern Med; 1993 Jan; 153(1):102-4. PubMed ID: 8422191
[TBL] [Abstract][Full Text] [Related]
3. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial).
Donders G; Bellen G; Byttebier G; Verguts L; Hinoul P; Walckiers R; Stalpaert M; Vereecken A; Van Eldere J
Am J Obstet Gynecol; 2008 Dec; 199(6):613.e1-9. PubMed ID: 18976735
[TBL] [Abstract][Full Text] [Related]
4. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
Ray D; Goswami R; Dadhwal V; Goswami D; Banerjee U; Kochupillai N
J Infect; 2007 Oct; 55(4):374-7. PubMed ID: 17692922
[TBL] [Abstract][Full Text] [Related]
5. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
[TBL] [Abstract][Full Text] [Related]
6. Variations in prothrombin time and international normalized ratio over 24 hours in warfarin-treated patients.
Bleske BE; Welage LS; Warren EW; Brown MB; Shea MJ
Pharmacotherapy; 1995; 15(6):709-12. PubMed ID: 8602377
[TBL] [Abstract][Full Text] [Related]
7. Cranberry does not affect prothrombin time in male subjects on warfarin.
Li Z; Seeram NP; Carpenter CL; Thames G; Minutti C; Bowerman S
J Am Diet Assoc; 2006 Dec; 106(12):2057-61. PubMed ID: 17126638
[TBL] [Abstract][Full Text] [Related]
8. The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.
Schwartz JI; Bugianesi KJ; Ebel DL; De Smet M; Haesen R; Larson PJ; Ko A; Verbesselt R; Hunt TL; Lins R; Lens S; Porras AG; Dieck J; Keymeulen B; Gertz BJ
Clin Pharmacol Ther; 2000 Dec; 68(6):626-36. PubMed ID: 11180023
[TBL] [Abstract][Full Text] [Related]
9. Standardizing the prothrombin time. Calibrating coagulation instruments as well as thromboplastin.
Becker DM; Humphries JE; Walker FB; DeMong LK; Bopp JS; Acker MN
Arch Pathol Lab Med; 1993 Jun; 117(6):602-5. PubMed ID: 8503731
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
Seidman LS; Skokos CK
Infect Dis Obstet Gynecol; 2005 Dec; 13(4):197-206. PubMed ID: 16338779
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy.
Anderson DR; Harrison L; Hirsh J
Arch Intern Med; 1993 Jun; 153(12):1441-7. PubMed ID: 8512435
[TBL] [Abstract][Full Text] [Related]
12. Excessive prolongation of prothrombin time among patients treated with warfarin and admitted to the emergency room.
Habib G; Nashashibi M; Khateeb A; Goichman S; Kogan A
Eur J Intern Med; 2008 Mar; 19(2):129-34. PubMed ID: 18249309
[TBL] [Abstract][Full Text] [Related]
13. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
Jonsson M; Hillarp A; Svensson P
Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149
[TBL] [Abstract][Full Text] [Related]
14. Tibolone (Livial) enhances warfarin-induced anticoagulation in postmenopausal women.
Elbers J; Hageluken C; Wadham A
Maturitas; 2007 Jan; 56(1):94-100. PubMed ID: 16887301
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulant therapy and international normalized ratios in swine.
McGlasson DL; Brickey DA; Doe RH
Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between prothrombin time international normalized ratio and thrombo test (%)].
Numata Y; Ogata Y; Arao K; Mizumasa Y; Wakita T; Haruguchi H; Araki H; Tsuji T; Mawatari K; Shimada K
J Cardiol; 2001 Dec; 38(6):327-35. PubMed ID: 11806090
[TBL] [Abstract][Full Text] [Related]
17. Safety of intramuscular influenza immunization among patients receiving long-term warfarin anticoagulation therapy.
Raj G; Kumar R; McKinney WP
Arch Intern Med; 1995 Jul; 155(14):1529-31. PubMed ID: 7605155
[TBL] [Abstract][Full Text] [Related]
18. The incidence, magnitude, and time course of the amiodarone-warfarin interaction.
Kerin NZ; Blevins RD; Goldman L; Faitel K; Rubenfire M
Arch Intern Med; 1988 Aug; 148(8):1779-81. PubMed ID: 3401099
[TBL] [Abstract][Full Text] [Related]
19. Reemergence of the International Normalized Ratio for the standardization of prothrombin time.
Morse EE; Panek S; Pisciotto P; Kiraly T; Bona R; Vose K; Rickles F
Ann Clin Lab Sci; 1993; 23(3):184-8. PubMed ID: 8323252
[TBL] [Abstract][Full Text] [Related]
20. Multicenter evaluation of six methods for predicting warfarin maintenance-dose requirements from initial response.
Sawyer WT; Poe TE; Canaday BR; Weiner JS; Williams DM; Webb CE; Ellison MJ
Clin Pharm; 1985; 4(4):440-6. PubMed ID: 3899472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
